10,000+ stock pitches from top investors available on joinyellowbrick.com
BAKER BROS. ADVISORS LP 13F Holdings
Holdings from the most recent 13F from BAKER BROS. ADVISORS LP
Filed: 2021-11-15 (Q3 2021) | Holdings: 122 | Value: $22.8B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| SGEN - Seagen Inc. | 35.26% | $8.0B | -29.34% | -27.75% | |||
| BGNE - BeiGene, Ltd. | 18.60% | $4.2B | -37.40% | -43.87% | -47.55% | ||
| INCY - Incyte Corporation | 9.67% | $2.2B | -0.49% | +3.75% | +17.33% | ||
| KOD - Kodiak Sciences Inc. | Add 4% ($52.2M) | 6.19% | $1.4B | -96.71% | -46.40% | -92.57% | |
| ASND - Ascendis Pharma A/S | Add 28% ($159.6M) | 3.18% | $723.9M | +6.75% | -22.83% | -24.71% | |
| ACAD - ACADIA Pharmaceuticals Inc. | 3.06% | $696.1M | +8.77% | +38.68% | -23.40% | ||
| BMRN - BioMarin Pharmaceutical Inc. | 2.59% | $589.0M | -29.65% | +12.28% | +3.99% | ||
| ARGX - argenx SE | 1.48% | $338.1M | +91.69% | +0.43% | +22.08% | ||
| PRLD - Prelude Therapeutics Inc. | 1.39% | $316.4M | -94.41% | -35.80% | -51.39% | ||
| NVTA - Invitae Corporation | Reduce 4% $(10.7M) | 1.23% | $280.7M | -50.00% | -85.31% | ||
| MRTX - Mirati Therapeutics, Inc. | 1.10% | $249.4M | -33.14% | -48.34% | |||
| ABCL - AbCellera Biologics Inc. | 0.92% | $209.4M | -87.61% | -39.88% | -10.92% | ||
| IGMS - IGM Biosciences, Inc. | 0.91% | $207.5M | -97.87% | -72.24% | -56.86% | ||
| BCRX - BioCryst Pharmaceuticals, Inc. | 0.80% | $182.7M | -8.90% | +67.46% | +9.24% | ||
| KYMR - Kymera Therapeutics, Inc. | Add 22% ($25.0M) | 0.62% | $140.1M | -51.51% | -32.14% | -52.25% | |
| PACB - Pacific Biosciences of California, Inc. | Add 70% ($57.3M) | 0.61% | $139.1M | -96.40% | -55.62% | -59.06% | |
| MDGL - Madrigal Pharmaceuticals, Inc. | 0.53% | $119.6M | +203.45% | -1.07% | -22.61% | ||
| LEGN - Legend Biotech Corporation | Add 42% ($35.4M) | 0.52% | $119.5M | -44.90% | -20.82% | -1.69% | |
| AMRN - Amarin Corporation plc | Reduce 17% $(23.4M) | 0.49% | $111.5M | -85.63% | -13.98% | -69.76% | |
| IMCR - Immunocore Holdings plc | 0.41% | $93.4M | -5.89% | -38.67% | +62.18% | ||
| HRTX - Heron Therapeutics, Inc. | 0.38% | $86.9M | -82.80% | -22.96% | -72.10% | ||
| CERS - Cerus Corporation | 0.37% | $83.5M | -82.11% | -21.41% | -44.37% | ||
| GBT - Global Blood Therapeutics, Inc. | 0.36% | $82.0M | +2.56% | ||||
| ALLK - Allakos Inc. | 0.33% | $74.4M | -92.10% | -90.88% | |||
| NRIX - Nurix Therapeutics, Inc. | 0.32% | $73.5M | -68.51% | -52.31% | -59.33% | ||
| DBVT - DBV Technologies S.A. | 0.31% | $71.6M | -73.15% | -52.41% | -57.56% | ||
| TIL - Instil Bio, Inc. | 0.31% | $69.6M | -93.49% | -38.38% | -90.48% | ||
| VERV - Verve Therapeutics, Inc. | 0.29% | $66.6M | -90.24% | -33.76% | -45.65% | ||
| VSTM - Verastem, Inc. | 0.29% | $66.2M | -79.85% | -56.59% | -87.11% | ||
| HZNP - Horizon Therapeutics Public Ltd Co | 0.29% | $65.6M | -10.37% | -30.58% | |||
| NBIX - Neurocrine Biosciences, Inc. | 0.29% | $64.9M | +40.02% | -2.26% | +28.24% | ||
| INSM - Insmed Incorporated | 0.26% | $59.4M | +130.51% | -20.66% | -40.40% | ||
| IMTX - Immatics N.V. | Add 3% ($1.8M) | 0.25% | $57.5M | -54.51% | -22.87% | -13.00% | |
| N/A - Apellis Pharmaceuticals, Inc. | New Purchase | 0.25% | $57.3M | ||||
| ADAP - Adaptimmune Therapeutics plc | 0.22% | $50.8M | -93.21% | -28.07% | -45.48% | ||
| RYTM - Rhythm Pharmaceuticals, Inc. | 0.22% | $50.5M | +373.96% | -48.76% | +97.91% | ||
| ZYME - Zymeworks Inc. | 0.22% | $49.6M | -41.02% | -62.07% | -59.65% | ||
| TVTX - Travere Therapeutics, Inc. | New Purchase | 0.22% | $49.5M | -48.95% | -3.13% | -28.08% | |
| BLUE - bluebird bio, Inc. | New Purchase | 0.21% | $47.8M | -97.84% | -43.47% | -37.80% | |
| TLIS - Talis Biomedical Corporation | 0.21% | $47.3M | -98.21% | -60.71% | -90.93% | ||
| FMTX - Forma Therapeutics Holdings, Inc. | 0.21% | $47.0M | -37.86% | ||||
| MRUS - Merus N.V. | 0.20% | $44.8M | +89.81% | -6.06% | -37.47% | ||
| N/A - Insmed Incorporated | 0.19% | $43.8M | |||||
| N/A - Sarepta Therapeutics, Inc. | 0.19% | $43.2M | |||||
| RARE - Ultragenyx Pharmaceutical Inc. | 0.18% | $40.1M | -57.68% | -11.49% | -56.20% | ||
| ALKS - Alkermes plc | New Purchase | 0.17% | $37.9M | +33.34% | +14.83% | -4.07% | |
| FLGT - Fulgent Genetics, Inc. | 0.16% | $36.1M | -77.74% | -29.28% | -61.37% | ||
| AVTE - Aerovate Therapeutics, Inc. | New Purchase | 0.15% | $34.7M | -47.82% | +13.12% | ||
| ALGS - Aligos Therapeutics, Inc. | New Purchase | 0.14% | $32.2M | -98.74% | -84.92% | -94.25% | |
| KNSA - Kiniksa Pharmaceuticals, Ltd. | 0.14% | $31.9M | +110.46% | -12.62% | +21.92% | ||
| APLS - Apellis Pharmaceuticals, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| AXSM - Axsome Therapeutics, Inc. | Reduce 100% | 0.00% | $0.00 | +156.72% | -17.38% | +34.47% | |
| BCAB - BioAtla, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| KRYS - Krystal Biotech, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| NLTX - Neoleukin Therapeutics, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| ADCT - ADC Therapeutics SA | Reduce 100% | 0.00% | $0.00 | ||||